GSK and SCYNEXIS announce agreement to commercialise and further develop Brexafemme
SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
Cipla has received 8 inspectional observations in Form 483
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
Valentas and Arnipin are indicated to reduce repeated hospitalization and the risk of cardiovascular death among adult patients with chronic mild to moderate heart failure
The company has been issued ‘Form 483’ with two observations
Subscribe To Our Newsletter & Stay Updated